CCNL2 Knockout HeLa Cell Line
Cat.No.:
EDC90277
Species:
Human
Cell Name:
HeLa
Gene:
CCNL2
Gene ID:
81669
Size:
1×10⁶cells
CCNL2 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90277 |
|---|---|
| Product Name | CCNL2 Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | CCNL2 |
| NCBI Gene ID | |
| Gene Synonyms | ANIA-6B|CCNM|CCNS|HCLA-ISO|HLA-ISO|PCEE|SB138 |
| Summary |
The protein encoded by this gene belongs to the cyclin family. Through its interaction with several proteins, such as RNA polymerase II, splicing factors, and cyclin-dependent kinases, this protein functions as a regulator of the pre-mRNA splicing process, as well as in inducing apoptosis by modulating the expression of apoptotic and antiapoptotic proteins. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying CCNL2 function, CCNL2 Knockout HeLa Cell Line or CCNL2 overexpression HeLa Cell Line?
The choice depends on the experimental question. CCNL2 (cyclin L2) is a less-characterized cyclin family member with characterized roles in splicing factor regulation. The Knockout line is appropriate for asking whether CCNL2 is required for predicted activities — CCNL2 is paralog of CCNL1 with characterized roles as a partner of cyclin-dependent kinases CDK11 and CDK12 in splicing factor phosphorylation and RNA processing. Overexpression is useful for studying CCNL2 in heterologous expression contexts.
For RNA processing research, the EDITGENE CCNL2 Knockout in HeLa provides a clean genetic background for characterizing CCNL2-specific functions. CCNL1 paralog expression analysis aids interpretation. Rescue with wild-type CCNL2 is the standard specificity control. The knockout is valuable for studying less-characterized cyclin L biology and emerging CDK11/CDK12-CCNL pathway research.
What are the application scenarios for this model?
Primary applications:
• CDK11/CDK12 partnership: CDK11-CCNL2 and CDK12-CCNL2 complex analysis.
• Splicing factor phosphorylation: SR protein phosphorylation analysis in CCNL2-null cells.
• CCNL family dissection: CCNL1 expression analysis to interpret CCNL2-specific functions.
• Alternative splicing: RNA-seq analysis of alternative splicing in CCNL2-null cells.
EDITGENE recommends this model for researchers investigating cyclin L family biology and CDK11/12-mediated RNA processing.
Is this CCNL2 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. CCNL2 rescue experiments require attention to cyclin architecture:
• Construct design: use a codon-modified CCNL2 sequence with a small C-terminal tag (FLAG, HA). CCNL2 has cyclin-box domains — preserve protein integrity.
• CDK-binding-deficient rescue: cyclin-box mutations disrupt CDK11/CDK12 binding.
• Functional readout: rescue should restore CCNL2-dependent splicing factor phosphorylation and alternative splicing patterns.
HeLa transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download